S. Bayle

627 total citations
17 papers, 149 citations indexed

About

S. Bayle is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, S. Bayle has authored 17 papers receiving a total of 149 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in S. Bayle's work include Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Diagnosis and Treatment (3 papers) and Synthesis and biological activity (2 papers). S. Bayle is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Diagnosis and Treatment (3 papers) and Synthesis and biological activity (2 papers). S. Bayle collaborates with scholars based in France, Réunion and Luxembourg. S. Bayle's co-authors include Piseth Seng, Andréas Stein, Dominique Casanova, Fanny Romain, Philippe Brouqui, Clarisse Rovery, C. Chouaïd, Pascal Sbragia, L. Falchero and J.B. Auliac and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Cancers.

In The Last Decade

S. Bayle

14 papers receiving 143 citations

Peers

S. Bayle
Heinz‐Gert Höffkes Germany
Ana B Clara B Menezes Brazil
S Ghione Italy
Nikhil Ghadyalpatil India
Johanna Konopacki France
Chun-Yen Ou Taiwan
Ingrīda Rumba-Rozenfelde Latvia
Shugo Kowata Japan
Hiromi Tamura Japan
Stefano Greco Italy
Heinz‐Gert Höffkes Germany
S. Bayle
Citations per year, relative to S. Bayle S. Bayle (= 1×) peers Heinz‐Gert Höffkes

Countries citing papers authored by S. Bayle

Since Specialization
Citations

This map shows the geographic impact of S. Bayle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Bayle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Bayle more than expected).

Fields of papers citing papers by S. Bayle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Bayle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Bayle. The network helps show where S. Bayle may publish in the future.

Co-authorship network of co-authors of S. Bayle

This figure shows the co-authorship network connecting the top 25 collaborators of S. Bayle. A scholar is included among the top collaborators of S. Bayle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Bayle. S. Bayle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Swalduz, Aurélie, Michèle Beau‐Faller, David Planchard, et al.. (2022). Efficacy of dabrafenib-trametinib combination in BRAF V600E-mutated metastatic non–small cell lung cancer: Results of the IFCT-2004 BLaDE cohort.. Journal of Clinical Oncology. 40(16_suppl). 9082–9082. 4 indexed citations
2.
Auliac, J.B., S. Bayle, Pascal Dô, et al.. (2020). Efficacy of Dabrafenib Plus Trametinib Combination in Patients with BRAF V600E-Mutant NSCLC in Real-World Setting: GFPC 01-2019. Cancers. 12(12). 3608–3608. 14 indexed citations
3.
Auliac, J.B., Pascal Dô, S. Bayle, et al.. (2019). Non-Small Cell Lung Cancer Patients Harboring HER2 Mutations: Clinical Characteristics and Management in a Real-Life Setting. Cohort HER2 EXPLORE GFPC 02–14. Advances in Therapy. 36(8). 2161–2166. 11 indexed citations
4.
5.
Seng, Piseth, et al.. (2015). The microbial epidemiology of breast implant infections in a regional referral centre for plastic and reconstructive surgery in the south of France. International Journal of Infectious Diseases. 35. 62–66. 61 indexed citations
6.
Gouriet, Frédérique, S. Bayle, Yvan Le Dolley, et al.. (2013). Infectious endocarditis detected by PET/CT in a patient with a prosthetic knee infection: Case report and review of the literature. Scandinavian Journal of Infectious Diseases. 45(7). 570–574. 4 indexed citations
7.
Tardy, Bernard, Anne Richard, Thomas Célarier, et al.. (2009). Traitement prophylactique de la maladie thromboembolique veineuse en soins palliatifs. La Presse Médicale. 38(9). 1235–1239. 3 indexed citations
8.
Tardy, Bernard, Anne Richard, Thomas Célarier, et al.. (2009). Traitement prophylactique de la maladie thromboembolique veineuse en soins palliatifs: Hétérogénéité des pratiques des médecins en réponse à 4 situations cliniques différentes. 38(9). 1235–1239. 1 indexed citations
9.
Bayle, S., Clarisse Rovery, Pascal Sbragia, Didier Raoult, & Philippe Brouqui. (2008). Stenotrophomonas maltophilia prosthetic valve endocarditis: a case report. Journal of Medical Case Reports. 2(1). 174–174. 14 indexed citations
10.
Vergnon, J.M. & S. Bayle. (2007). Carcinoïdes bronchiques : place de l’endoscopie interventionnelle. Revue des Maladies Respiratoires. 24. 76–78.
11.
Vergnenègre, A., Christophe Combescure, P. Fournel, et al.. (2006). Cost-minimization analysis of a phase III trial comparing concurrent versus sequential radiochemotherapy for locally advanced non-small-cell lung cancer (GFPC-GLOT 95–01). Annals of Oncology. 17(8). 1269–1274. 11 indexed citations
12.
Metges, Jean‐Philippe, et al.. (2006). Traitement d’un carcinome épidermoïde primitif du pancréas par gemcitabine. Gastroentérologie Clinique et Biologique. 30(10). 1217–1220. 5 indexed citations
13.
14.
Bayle, S., Jean-Philippe Dalès, Lucile Andrac‐Meyer, et al.. (2005). P17 - Toxidermies psoriasiformes induites par l’infliximab (Remicade®) : effet variable du changement d’anti-TNFδ. Annales de Dermatologie et de Vénéréologie. 132. 81–81. 1 indexed citations
15.
Bayle, S., P Rossi, Jean-Philippe Dalès, et al.. (2004). Polype fibro-inflammatoire de l'iléon révélé par une invagination. À propos d'un cas familial. La Revue de Médecine Interne. 26(3). 233–237. 7 indexed citations
16.
Bayle, S., R. Descourt, S. Gouva, Casey L. Daniel, & G. Robinet. (2004). Efficacité du gefitinib (Iressa) pour le traitement d’un carcinome bronchioloalvéolaire inopérable. Revue des Maladies Respiratoires. 21(1). 153–157. 1 indexed citations
17.
Vergnenègre, A., Christophe Combescure, P. Fournel, et al.. (2003). O-8 Cost-analysis of a phase III trial comparing a concurrent versus a sequential chemo-radiotherapy (CT-RT) for locally advanced non small cell lung cancer (NSCLC). Lung Cancer. 41. S6–S7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heinz‐Gert Höffkes Breakdown of academic impact, for papers by Ana B Clara B Menezes Breakdown of academic impact, for papers by S Ghione Breakdown of academic impact, for papers by Nikhil Ghadyalpatil Breakdown of academic impact, for papers by Johanna Konopacki Breakdown of academic impact, for papers by Chun-Yen Ou Breakdown of academic impact, for papers by Ingrīda Rumba-Rozenfelde Breakdown of academic impact, for papers by Shugo Kowata Breakdown of academic impact, for papers by Hiromi Tamura Breakdown of academic impact, for papers by Stefano Greco
Rankless by CCL
2026